Vestrant 250mg Injection
Prescription Required
Product introduction
Vestrant 250mg Injection is an estrogen blocker. It is used in the treatment of breast cancer in women who have gone through menopause. It works by adjusting the level of estrogen and slow down the growth of cancer cells.
Vestrant 250mg Injection is used to treat an advanced form of breast cancer by blocking the effects of a chemical that can lead to the cancerous growth
Vestrant 250mg Injection is used to treat an advanced form of breast cancer by blocking the effects of a chemical that can lead to the cancerous growth
Uses of Vestrant Injection
Benefits of Vestrant Injection
In Breast cancer
Vestrant 250mg Injection relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on the cancer to stop its growth. It is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully.
Side effects of Vestrant Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Vestrant
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Vestrant Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Vestrant 250mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Vestrant 250mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Vestrant 250mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
SAFE
Vestrant 250mg Injection does not usually affect your ability to drive.
Kidney
CAUTION
Vestrant 250mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Vestrant 250mg Injection may be needed. Please consult your doctor.
Limited information is available on the use of Vestrant 250mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Limited information is available on the use of Vestrant 250mg Injection in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
CAUTION
Vestrant 250mg Injection should be used with caution in patients with liver disease. Dose adjustment of Vestrant 250mg Injection may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Vestrant 250mg Injection
₹17000.0/Injection
Fulvenat 250mg Injection
Natco Pharma Ltd
₹18000/injection
6% costlier
Strantas 250mg Injection
Intas Pharmaceuticals Ltd
₹13300.08/injection
22% cheaper
Fulviglen 250mg Injection
Glenmark Pharmaceuticals Ltd
₹12400/injection
27% cheaper
Fuvestrol Injection
Cadila Pharmaceuticals Ltd
₹13511/injection
21% cheaper
Faslodex 250mg Injection
AstraZeneca
₹25573/injection
50% costlier
Quick tips
- Vestrant 250mg Injection is used for the treatment of hormone dependent breast cancer.
- It should only be taken by women who have undergone menopause and cannot become pregnant.
- It is given as a slow injection into the muscles (intramuscular) of your buttock.
- Inform your doctor if you have any bleeding disorder, kidney or liver disease or if you are receiving any medicines to prevent blood clots.
- Do not take Vestrant 250mg Injection if you are pregnant or breastfeeding.
Fact Box
Chemical Class
Estrogens Derivatives
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Estrogen receptor antagonist
Patient concerns
FAQs
What is Vestrant 250mg Injection and what is it used for?
Vestrant 250mg Injection contains a medicine, Fulvestrant which is used to treat breast cancer in women who have gone through menopause.
How and in what dose should I use Vestrant 250mg Injection?
Your doctor would advise you the exact dose of this medicine. It is given as a slow (1 to 2 minutes) intramuscular (deep into the muscle) injection in your buttocks. It is administered by a medical healthcare professional only.
What are the common side effects of using Vestrant 250mg Injection?
The common side effects associated with this medicine are headache, vomiting, urinary tract infection, diarrhea, vaginal bleeding, low platelets count and back pain. If any of these side effects bother you, consult with your doctor.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.
- Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1759-60.
- Drugs.com. Fulvestrant. [Accessed 03 Apr. 2019] (online) Available from:
- Fulvestrant. Luton, Bedfordshire: AstraZeneca UK Limited; 2004 [revised 6 Sep 2018]. [Accessed 03 Apr. 2019] (online) Available from:
- Fulvestrant. Cheshire, England: AstraZeneca UK Limited; 2002 [revised Jul. 2011]. [Accessed 03 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
Marketer details
Name: Getwell Pharma (I) Pvt Ltd
Address: 464, Udyog Vihar, Phase-V Sector 19, Gurugram Haryana 122016
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹17000
Inclusive of all taxes
5.0 ml in 1 vial
SOLD OUT